×
About 10 results

ALLMedicine™ Alg1-cdg Center

Research & Reviews  4 results

Clinical, biochemical and molecular phenotype of congenital disorders of glycosylation:...
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7789416
Orphanet Journal of Rare Diseases; Bogdańska A, Lipiński P et. al.

Jan 8th, 2021 - Congenital disorders of glycosylation (CDG) result from defects in the synthesis of glycans and the attachment of glycans to proteins and lipids. Our study aimed to describe the clinical, biochemical, and molecular findings of CDG patients, and to...

Foetal phenotype of ALG1-CDG caused by paternal uniparental disomy 16.
https://doi.org/10.1080/01443615.2020.1786031
Journal of Obstetrics and Gynaecology : the Journal of Th... Lei YL, Zhen L et. al.

Aug 20th, 2020 - Foetal phenotype of ALG1-CDG caused by paternal uniparental disomy 16.|2020|Lei YL,Zhen L,Xu LL,Yang YD,Li DZ,|

ALG1-CDG (CDG-Ik)
https://rarediseases.info.nih.gov/diseases/9838/alg1-cdg-cdg-ik

Jul 1st, 2016 - The following summary is from Orphanet, a European reference portal for information on rare diseases and orphan drugs. Orpha Number: 79327 Definition A severe form of congenital disorders of N-linked glycosylation characterized by severe developme...

Serum transferrin carrying the xeno-tetrasaccharide NeuAc-Gal-GlcNAc2 is a biomarker of...
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4822552
Journal of Inherited Metabolic Disease; Bengtson P, Ng BG et. al.

Sep 4th, 2015 - ALG1-CDG (formerly CDG-Ik) is a subtype of congenital disorders of glycosylation (CDG) where the genetic defect disrupts the synthesis of the lipid-linked oligosaccharide precursor required for N-glycosylation. The initial step in the investigatio...

see more →